Book contents
- Practical Emergency Resuscitation and Critical Care
- Practical Emergency Resuscitation and Critical Care
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 General Critical Care
- Section 2 Infectious Disease Emergencies
- 5 Covid-19
- 6 Sepsis and Septic Shock
- 7 Pneumonia
- 8 Meningitis and Encephalitis
- 9 Infective Endocarditis
- 10 Necrotizing Soft Tissue Infections
- 11 Complications of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)
- Section 3 Neurological Emergencies
- Section 4 Cardiovascular Emergencies
- Section 5 Respiratory Emergencies
- Section 6 Gastrointestinal Emergencies
- Section 7 Renal Emergencies
- Section 8 Hematology–Oncology Emergencies
- Section 9 Endocrine Emergencies
- Section 10 Environmental Emergencies
- Section 11 Trauma
- Section 12 End of Life
- Index
- References
5 - Covid-19
from Section 2 - Infectious Disease Emergencies
Published online by Cambridge University Press: 02 November 2023
Book contents
- Practical Emergency Resuscitation and Critical Care
- Practical Emergency Resuscitation and Critical Care
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 General Critical Care
- Section 2 Infectious Disease Emergencies
- 5 Covid-19
- 6 Sepsis and Septic Shock
- 7 Pneumonia
- 8 Meningitis and Encephalitis
- 9 Infective Endocarditis
- 10 Necrotizing Soft Tissue Infections
- 11 Complications of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)
- Section 3 Neurological Emergencies
- Section 4 Cardiovascular Emergencies
- Section 5 Respiratory Emergencies
- Section 6 Gastrointestinal Emergencies
- Section 7 Renal Emergencies
- Section 8 Hematology–Oncology Emergencies
- Section 9 Endocrine Emergencies
- Section 10 Environmental Emergencies
- Section 11 Trauma
- Section 12 End of Life
- Index
- References
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the pandemic declared in March 2020. While many of the manifestations (i.e., acute respiratory distress syndrome [ARDS]) are similar to other severe respiratory viruses, there is an increasing number of specific therapeutics found to be effective in combating coronavirus disease 2019 (COVID-19). As data emerge on the optimal treatment of COVID-19, the recommendations in this chapter are based on the current consensus from large global health and infectious disease authorities but are subject to evolution of the evidence.
- Type
- Chapter
- Information
- Practical Emergency Resuscitation and Critical Care , pp. 49 - 57Publisher: Cambridge University PressPrint publication year: 2023
References
Avari, H, Hiebert, RJ, Ryzynski, AA, et al. Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical care environment. Am J Respir Crit Care Med 2021;203(9):1112–1118. https://doi.org/10.1164/rccm.202008-3070OCCrossRefGoogle Scholar
Brower, RG, Matthay, MA, Morris, A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New Engl J Med 2000;342(18):1301–1308.Google ScholarPubMed
Gottlieb, RL, Nirula, A, Chen, P, et al. Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA 2021;325(7):632–644. https://doi.org/10.1001/jama.2021.0202CrossRefGoogle ScholarPubMed
Janiaud, P, Axfors, C, Schmitt, AM, et al. Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. JAMA 2021;325(12):1185–1195. https://doi.org/10.1001/jama.2021.2747CrossRefGoogle ScholarPubMed
Korley, FK, Durkalski-Mauldin, V, Yeatts, SD, et al. Early convalescent plasma for high-risk outpatients with COVID-19. N Engl J Med 2021;385(21):1951–1960. https://doi.org/10.1056/NEJMoa2103784CrossRefGoogle ScholarPubMed
Libster, R, Pérez, MG, Wappner, D, et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N Engl J Med 2021;384(7):610–618. https://doi.org/10.1056/NEJMoa2033700CrossRefGoogle ScholarPubMed
Saniasiaya, J, Islam, MA, Abdullah, B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): A meta-analysis of 27,492 patients. Laryngoscope 2021;131(4):865–878. https://doi.org/10.1002/lary.29286CrossRefGoogle Scholar
Silva, FAFD, Brito, BB, Santos, MLC, et al. COVID-19 gastrointestinal manifestations: A systematic review. Rev Soc Bras Med Trop 2020;53:e20200714. https://doi.org/10.1590/0037-8682-0714-2020CrossRefGoogle ScholarPubMed
Solomon, IH, Normandin, E, Bhattacharyya, S, et al. Neuropathological features of Covid-19. N Engl J Med 2020;383(10):989–992. https://doi.org/10.1056/NEJMc2019373CrossRefGoogle ScholarPubMed
Wong, HYF, Lam, HYS, Fong, AHT, et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020;296(2):E72–E78.CrossRefGoogle ScholarPubMed
Zhao, W, Zhong, Z, Xie, X, et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. Am J Roentgenol 2020;214(5):1072–1077.CrossRefGoogle ScholarPubMed